Virtual Event Preview: Writing the Future of Cancer Research
The last decade has seen incredible breakthroughs in the fight against cancer, and at Twist we’re fortunate to work with many innovators in the field. Join us March 17th for the first in our series of Writing the Future events, focused on Cancer Research. We will bring together scientists working across the full spectrum of this fast-evolving discipline to share their work and discuss what the future may hold.
Driving forward on target identification and drug development
Tools such as CRISPR and single-cell sequencing are revolutionizing how researchers approach drug target identification, and advances in biologic and cell therapy development help us imagine a future where cancer is merely a chronic illness rather than a deadly disease.
At Writing the Future of Cancer Research you’ll hear from speakers working to discover and develop novel treatments – including next-generation T-Cell therapies and multispecific antibodies. Talks include:
- Targeting Tumor Mutations with Personalized T-cell Therapy of Cancer - Gavin Bendle, Neogene Therapeutics
- Identifying and Cloning Neoepitope Specific, CD4+ T cells from Newly Diagnosed Glioma Patients in a Phase I Vaccination Trial Targeting Mutant IDH1 - Edward Green, DKFZ
- BEAT 2.0 – Ichnos’ Next Generation Bi- and Multi-specific Antibody Platform - Carole Estoppey, Ichnos Sciences
- Revealing Cancer Dependencies and Determinants of Therapeutic Response Using CRISPR - Luke Gilbert, University of California, San Francisco.
Diving into disease detection
Our ability to get treatments to the right patients at the right time improves with earlier and more sensitive detection. If you’d like to hear how scientists are setting up and running pipelines for monitoring and studying cancer look no further:
- No More Arrays: Genotyping by Sequencing Enables Economical and Improved Association Studies - Goncalo Abecasis, Regeneron Genetics Center
- NGS methylation in Early Cancer Detection – Kenneth Chahine, Helio Health
- A Custom Hybrid Capture-based NGS Assay to Detect Circulating Tumor DNA - Maartje Geerlings, Radboud University Medical Center
- Twist Targeted Panels in Clinical Genetic Diagnostics - Yuriy Shevschenko, Sema4
- Developing Blood Biopsy Technology Using a New Canine Exome Capture - Kate Megquier, The Broad Institute of MIT and Harvard
- Enabling Clinical Trials and Translational Studies with Twist - Dr. Shubha Anand and Ezequiel Martin, University of Cambridge
We know that virtual events are never going to replace the experience of meeting your scientific peers in person, but the pandemic has shown us that it is more important than ever for the scientific community to be working together and exchanging ideas. We’ve kept this front of mind as we’ve planned this event: we’ll be breaking out for virtual networking in Wonder – where you can meet the speakers and other attendees – and we’ll be bringing our speakers together for a live panel discussion. Don’t miss out!
To register for this free half-day event visit our registration page. And it wouldn’t be a Twist conference without the same great Twist swag you’d get at a physical event, but delivered to your door*.
*All swag is optional. Attendee addresses are collected for the delivery of swag, and will not be used for any other purpose.
What did you think?